Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001144204-17-005958
Filing Date
2017-02-03
Accepted
2017-02-03 17:14:39
Documents
7
Period of Report
2017-02-03

Document Format Files

Seq Description Document Type Size
1 PREM14A v457435_prem14a.htm PREM14A 2424456
2 GRAPHIC image_001.jpg GRAPHIC 3947
3 GRAPHIC image_002.jpg GRAPHIC 3778
4 GRAPHIC pg2img1_prem14a.jpg GRAPHIC 15052
5 GRAPHIC pg5img1_prem14a.jpg GRAPHIC 15254
6 GRAPHIC proxy1_prem14a.jpg GRAPHIC 280184
7 GRAPHIC proxy2_prem14a.jpg GRAPHIC 194430
  Complete submission text file 0001144204-17-005958.txt   3132316
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36439 | Film No.: 17573046
SIC: 3826 Laboratory Analytical Instruments